SUNY - SLE Treatment with NAC - (SNAC)

Study Phase: Phase II - Drug

Condition(s): Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE) Treatment with N-acetylcysteine (NAC) (SNAC)

ClinicalTrials.gov NCT ID: NCT00775476

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_monica-hosler

Monica Hosler

Primary Contact - Study Coordinator

484-658-4567
monica.hosler@sluhn.org

profile_jarheen-jaffari

Farheen Jaffari, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today